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Putative subunits of the rat mesangial KATP: A type 2B
sulfonylurea receptor and an inwardly rectifying K⫹ channel
BALÁZS SZAMOSFALVI, PEDRO CORTES, REBECCA ALVIANI, KENICHIRO ASANO, BRUCE L. RISER,
GARY ZASUWA, and JERRY YEE
Department of Medicine, Division of Nephrology and Hypertension, Henry Ford Hospital, Detroit, Michigan, USA

Putative subunits of the rat mesangial KATP: A type 2B sulfonylurea receptor and an inwardly rectifying Kⴙ channel.
Background. Sulfonylurea agents exert their physiological
effects in many cell types via binding to specific sulfonylurea
receptors (SUR). SUR couple to inwardly-rectifying K⫹ channel (Kir6.x) to form tetradimeric ATP-sensitive K⫹ channels
(KATP). The SUR subunits confer ATP-sensitivity on KATP and
also provide the binding sites for sulfonylureas and other pharmacological agents. Our previous work demonstrated that the
exposure of mesangial cells (MC) to sulfonylureas generated
profound effects on MC glucose uptake and matrix metabolism
and induced heightened cell contractility in association with
Ca2⫹ transients. Because these responses likely resulted from
the binding of sulfonylurea to a mesangial SUR2, we subsequently documented [3H]-glibenclamide binding to MC and
the gene expression of several mesangial SUR2 transcripts.
From these data, we inferred that MC expressed the components of a mesangial KATP and sought to establish their presence
in primary MC.
Methods. To obtain mesangial SUR2 cDNA sequences,
rapid amplification of cDNA ends (RACE) was utilized. DNA
sequences were established by the fluorescent dye termination
method. Gene expression of mesangial SUR2 and Kir6.1/2 was
examined by reverse transcription polymerase chain reaction
(RT-PCR) and Northern analysis. SUR2 proteins were identified by immunoblotting of mesangial proteins from membraneenriched fractions with polyclonal antiserum directed against
SUR2.
Results. RACE cloning yielded two mesangial SUR2 cDNAs
of 4.8 and 6.7 kbp whose open reading frames translated proteins of 964 and 1535 aa, respectively. Using probes specific to
each cDNA, the presence of a unique, 5.5 kbp serum-regulated
mesangial SUR2 splice variant was established. The sequence
of this mesangial SUR2 (mcSUR2B) shares identity with the
recently cloned rat SUR2B (rSUR2B), but, in comparison to
rSUR2B, is truncated by 12 exons at the N-terminus where it
contains a unique insert of 16 aa. Immunoblotting studies with
anti-SUR2 antiserum demonstrated SUR2 proteins of 108 and
170 kD in membrane-enriched fractions of MC protein extracts.
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Complementary studies showed abundant gene expression of
Kir6.1, thereby establishing gene expression of both components of KATP.
Conclusions. Based upon analogy to vascular smooth muscle
cells (VSMC), there are at least two putative mesangial KATP
that most likely represent hetero-octamers, comprised of either
rSUR2B or mcSUR2 in complex with Kir6.1. Our results define
the mesangial SUR2B as the possible first link in a chain of
cellular events that culminates in MC contraction and altered
extracellular matrix metabolism following exposure to sulfonylureas. In addition, our results serve as the basis for the
future elucidation of the electrophysiologic characteristics of
the mesangial KATP and the study of endogenous regulators of
mesangial cell contractility.

Sulfonylureas such as tolazamide and glibenclamide
are oral hypoglycemic agents that are frequently utilized
during the treatment of type 2 diabetes mellitus [1]. The
elucidation of the mechanism by which these agents augment pancreatic ␤ cell insulin secretion via their high
affinity type-1 sulfonylurea receptors (SUR1) has impelled
a burgeoning field of investigation into pancreatic and
non-pancreatic SUR [2]. These receptors are members
of the cystic fibrosis transmembrane regulator (CFTR)/
multidrug resistance protein (MRP) subfamily that is
subsumed within the adenosine 5⬘-triphosphate (ATP)binding cassette (ABC) superfamily [3, 4]. The two SUR
genes, SUR1 and SUR2, are encoded on separate chromosomes and have been respectively designated, ABCC8
and ABCC9 [5]. The SUR are predicted to have 17 transmembrane-spanning helices organized into three domains designated TM0, TM1, and TM2, separated by
two intracytoplasmic loops labeled NBF1 and NBF2,
each containing nucleotide-binding motifs. The SUR differ in their affinity for sulfonylureas and in their tissue
distribution. SUR1 is a high-affinity receptor expressed
by pancreatic ␤ cells and brain, while the low-affinity
SUR2 is more ubiquitously expressed [2]. There are two
major alternatively spliced SUR2 variants, SUR2A and
SUR2B, and the former is chiefly found in heart and
skeletal muscle, while the latter is localized to brain,
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heart, liver, kidney, intestine, and vascular smooth muscle [6, 7].
The ATP-sensitive K⫹ channels (KATP) are heterooctamers of two subunits, a SUR and a weak inwardlyrectifying K⫹ channel (Kir6.x) that associate with each
other in a stoichiometry of 4:4. Ion-channel closure is
mediated by sulfonylurea binding or by increases of the
cytoplasmic ATP:ADP ratio. In KATP, SUR1 or SUR2
regulates the Kir6.x ion pore to which it is coupled [8–16].
The prototypical ␤ cell KATP is a tetradimer of SUR1
and Kir6.2, whereas the cardiac and vascular smooth
muscle KATP are represented by (SUR2A:Kir6.2)4 and
(SUR2B:Kir6.1/2)4, respectively [17–24]. In previous studies, we established that the sulfonylurea tolazamide stimulated rat mesangial cells (MC) to secrete increased
amounts of collagen [25, 26]. As in other extrapancreatic
tissues in which sulfonylureas amplify glucose uptake, we
established that the enhancement of MC glucose uptake
occurred coincident with increased cytosol-to-membrane
translocation of the glucose transporter, GLUT1 [26, 27].
The augmentation of hexose uptake was associated with
an increased secretion of autocrine transforming growth
factor beta-1 (TGF-␤1) and collagen accumulation. In
addition, glibenclamide induced sustained oscillatory
Ca2⫹ transients in MC that coincided with heightened
cell contractility [28–33]. Further postulation that these
biological effects resulted from binding of sulfonylureas
to membranous receptors resulted in the initial characterization of several low-affinity MC SUR2. One of these
was represented by a unique and dominant 5.5 kb SUR2
transcript, which we identified as mesangial SUR2B
(mcSUR2B) [28]. With the prospect that this transcript
and possibly others encoded the SUR2 subunit of a mesangial KATP, we initiated a series of investigations to
characterize the components that would comprise this
channel. The initial molecular characterization of the
mesangial KATP would thus render greater insight toward
our understanding of the cell-signaling events underlying
our previously observed functional data regarding sulfonylureas and MC.
METHODS
Animals
Male Munich-Wistar rats, weighing 150 to 200 g, were
obtained from Charles River Laboratories (Wilmington,
MA, USA). Animals were housed in accordance with good
practice guidelines established by AALAC-approved
animal care facilities of Henry Ford Hospital. Animals
were fed standard Purina rat chow (Ralston Purina Co.,
St. Louis, MO, USA) and permitted free access to water.
Reagents
Insulin-transferrin-selenium pre-mix was obtained from
Becton Dickinson Biosciences (Franklin Lakes, NJ, USA).

Dimethyl sulfoxide (DMSO), glibenclamide, antibiotics, Tween-20, and morpholinopropane sulfonic acidEDTA-sodium acetate (MESA) buffer were purchased
from Sigma-Aldrich Co. (St. Louis, MO, USA). RPMI
1640 culture medium, fetal calf serum (FCS) and RNA
sizing ladders were obtained from Life Technologies
(Gaithersburg, MD, USA). QuikHyb solution was purchased from Stratagene (La Jolla, CA, USA). SMARTRACE娃 cloning kits and Advantage cDNA PCR enzyme mixes were obtained from Clontech (Palo Alto,
CA, USA). TOPO TA cloning kits and pCR2.1/TOPO
vectors were purchased from Invitrogen (Carlsbad, CA,
USA). RNA STAT-60 reagent was obtained from TelTest, Inc. (Friendswood, TX, USA). Poly(A)⫹ RNA was
isolated by magnetic bead separation (Roche Molecular Biochemicals, Indianapolis, IN, USA). [␣-32P]dCTP
(3000 Ci/mmol) was purchased from New England Nuclear (Boston, MA, USA). Bicinchoninic acid protein
assay kits were purchased from Pierce Labs (Rockford,
IL, USA). Sodium dodecyl sulfate-polyacrylamide gels
(10%) were obtained from Bio-Rad (Hercules, CA,
USA). Chemiluminescent detection system kits (ECL)
were purchased from Amersham Pharmacia Biotech
(Piscataway, NJ, USA). The 4.3 kbp Eco RI restriction
of rat SUR2 cDNA (pJGAR7) was generously provided
by Dr. Charles Burant (University of Michigan, Ann
Arbor, MI, USA). Kir6.1/2 primer sets were gifts of Dr.
Stephen C. Hebert (Yale Univ., New Haven, CT, USA).
Rabbit anti-SUR2 immune serum was kindly donated to
our laboratory by Dr. Susumu Seino (Chiba University,
Tokyo, Japan).
Tissue culture
The cells used in all studies were primary MC outgrowths of glomerular explants of Munich-Wistar rats
or our well characterized cloned rat mesangial cell line
16KC2 [26–28]. The latter are spindle-shaped cells that
form characteristic hillocks in confluent tissue cultures
and stain positively for vimentin, desmin and ␣-smooth
muscle actin, but not for cytokeratin or factor VIII. Cellular contraction occurs following exposure to either angiotensin II or arginine vasopressin. These cells also bear
atrial natriuretic peptide (ANP) receptors and the Thy-1
antigen on their surfaces. Except where noted, primary
MC or 16KC2 were seeded at a density of 5,000 cells
per cm2 and cultured to near-confluence in RPMI 1640
medium, containing 8 mmol/L glucose, antibiotics (penicillin 100 U/mL; streptomycin 100 g/mL) and 20%
serum.
Cloning by rapid amplification of cDNA
ends (RACE)
Poly(A)⫹ RNA was isolated on magnetic beads from
primary cell cultures at passage 8. RACE cloning was
carried out with the SMART-RACE娃 system [7]. Briefly,
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Table 1. Gene-specific polymerase chain reaction (PCR) primers
Primer
GSP1B
GSP2B
GSP3B
GSP4B
SUR013F
SURORF5
SUR227R
KIR61–2F
KIR61–2R
KIR62–5F
KIR62–3R
KIR62ORF5
KIR62ORF3
KIR61ORF5
KIR61ORF3
SUR2BORF5
SUR2B3NT
SURS4508F

Sequence
5⬘-tccttccagggtctgcatctcaccaa-3⬘
5⬘-AGGTGACGAACGGATACTTCTCATGG-3⬘
5⬘-aggaggagagacgatttgccacaacc-3⬘
5⬘-TGACATTCGAATTCCAACAGGTCAGC-3⬘
5⬘-CCTGGAGGTTCAGACTCTTGG-3⬘
5⬘-GTCGACGTCCTTCAAGATGGACAGAAC
ACTGC-3⬘
5⬘-gccttaggaagcagtgttctgtccat-3⬘
5⬘-AGCCACTGACCTTGTCAACC-3⬘
5⬘-ggagtcatgaattgcacctt-3⬘
5⬘-CGTCACAAGCATCCACTCCT-3⬘
5⬘-cacctgcatatgaatggtgg-3⬘
5⬘-GGCCAACGGAGCCATGCTGT-3⬘
5⬘-ggacaaggaatccggagagatgc-3⬘
5⬘-GGAAGATGCTGGCCAGGAAGAGC-3⬘
5⬘-ggattctgatgggcactggtttc-3⬘
5⬘-GCAGGCGGTTGGAAGGTAGATCA-3⬘
5⬘-catgtccgcacgaacgaacgag-3⬘
5⬘-GGCTCTGGGAGGCTCT-3⬘

Upper case letters denote the forward primer and lower case letters the reverse
primer.

1 g of MC poly(A)⫹ RNA was used as template in
separate reverse transcription reactions that yielded 5⬘and 3⬘-RACE ready single-stranded cDNA libraries.
The primary 5⬘-RACE reactions were carried out with
the primers UPM and GSP1B (Table 1) and nested 5⬘RACE reactions with primers NUP and GSP3B. Primary
3⬘-RACE reactions were carried out with the primers
UPM and GSP2 and nested 3⬘-RACE reactions with
primers NUP and GSP4B. The 0.6 and 2.5 kbp 5⬘-RACE
and the 3.9 and 4.3 kbp 3⬘-RACE generated amplicons
were gel-purified for direct T-A subcloning into the
pCR2.1/TOPO vector. Automated fluorescent DNA sequencing of the mcSUR2B and rSUR2B RACE fragments was performed on both strands by the ABI威 Prism
system with the Big Dye娃 Terminator Sequencing protocol (Applied Biosystems, Foster City, CA, USA). Consensus sequences were analyzed with MacVector 6.0 and
AssemblyLIGN software (Genetics Computer Group,
Inc., Madison, WI, USA) [34]. Finally, to establish the
presence of full length, contiguous SUR2 coding sequences as predicted from the RACE cloning results,
gene-specific primers SUR2BORF5 and SUR2BORF3
from rSUR2B and SURORF5 and SUR2BORF3 (from
mcSUR2B) (Table 1) were designed to amplify the full
coding sequences of the respective cDNAs. The 5⬘RACE ready, single-stranded primary MC cDNA library
was used as template in RT-PCR reactions. Nucleotide
sequences were verified by bidirectional sequencing.
Northern analysis
Total RNA was isolated from 16KC2 cells, primary
MC at passage 8 and from rat kidney, heart and brain
in RNA STAT-60 solution [34]. Twenty-microgram aliquots of total RNA were fractionated on 0.4 mol/L form-
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aldehyde gels at 100V. RNA was transferred to charged
nylon membranes by capillary action, UV light-crosslinked and hybridized at 68⬚C in QuikHyb to cDNA
probes, generated by random-priming in the presence of
[␣-32P]dCTP. To evaluate SUR2 gene expression, three
cDNA fragments were designed as templates for probe
synthesis. The first probe was unique to the full rSUR2B
sequence and synthesized from a 1.9 kbp Sac I fragment
of the 2.5 kbp 5⬘-RACE product. A second 215 bp probe
was generated by polymerase chain reaction (PCR) with
primers, SUR013F and SUR227R, unique to the 5⬘mcSUR2B sequence. A third probe was designed to detect both mesangial SUR2 transcripts and was a 4.3 kbp
Eco RI restriction fragment of pJGAR7. Multiple 20-g
aliquots from the same RNA harvest from 16KC2 cells
were probed in Northern analysis with the described
probes. Changes in SUR2 gene expression in response
to glibenclamide were studied in serum-deprived halfconfluent cultures, 24 and 48 hours following the addition of 5 M glibenclamide or vehicle. In these experiments, 20 g aliquots of RNA were probed with
pJGAR7 during Northern analysis [28]. The 1.2 kbp coding sequences of Kir6.1 and Kir6.2 were used as templates for specific probe generation in Northern analysis
of RNA derived from primary MC and 16KC2 cells,
kidney cortex, and the positive control, heart. Membranes were washed twice at 25⬚C for 10 minutes in
2⫻ standard sodium citrate (SSC)/0.1% sodium dodecyl
sulfate (SDS) and once at 60⬚C for 20 minutes in 0.1⫻
SSC/0.1% SDS. Membranes were autoradiographed and
films examined after 12 to 72 hours at ⫺70⬚C. These
experiments were conducted three times.
Microdissection of glomeruli and RNA isolation
for RT-PCR
Male Munich-Wistar rats were sacrificed and microdissection of glomeruli and RNA isolation was performed
as described previously [35].
Reverse transcription-polymerase chain reaction
Reverse transcription-polymerase chain reaction (RTPCR) was carried out on 1 g of total RNA extracted
from rat tissues, 20 ng of MC poly(A)⫹ RNA, or 5 L
of glomerular RNA isolate with a single tube system. The gene expression of previously described major
SUR2 splice variants was explored by RT-PCR in tissues and primary MC [6]. Primers SURS4508F and
SUR2B3NT were designed to specifically amplify a 446
bp SUR2B fragment and a 621 bp SUR2A fragment, to
fully resolve whether MC expressed the characteristic
N-terminal 38A exon of cardiac SUR2A [7, 11]. Primers,
SUR013F and SUR227R, were designed to specifically
amplify a 215 bp fragment of the unique 5⬘-mcSUR2B
sequence. In separate experiments conducted to detect
Kir6.x gene expression by primary MC, we used the
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Kir6.1 gene-specific primer pair, KIR61-2F and KIR612R, and the Kir6.2 gene-specific primer pair, KIR62-5F
and KIR62-3R, which were designed to amplify, respectively, a 402 bp and a 318 bp fragment. Amplicons were
visualized on ethidium bromide stained gels. Finally, to
obtain templates for radiolabeling in Northern blotting
studies, the 1.2 kbp coding sequences of Kir6.1 and Kir6.2
were amplified by RT-PCR of MC poly(A)⫹ RNA and
heart total RNA with sequence-specific primer pairs for
Kir6.1, KIR61ORF5 and KIR613ORF3, and for Kir6.2,
KIR62ORF5 and KIR62ORF3, respectively [15, 36]. Nucleotide sequences of the amplicons were verified by
DNA sequencing. Three independent experiments were
conducted.
Immunoblotting
Confluent primary MC and 16KC2 monolayers were
scraped into an ice-cold buffer (pH 7.4), containing 20
mmol/L HEPES, 2 mmol/L ethylenediaminetetraacetic
acid (EDTA), 250 mmol/L sucrose, 0.1 mmol/L phenylmethylsulfonyl fluoride (PMSF), 1 mmol/L pepstatin,
and 1 mmol/L leupeptin, then immediately homogenized
in a glass dounce [26]. Brain tissue was snap-frozen in
liquid nitrogen immediately following sacrifice of the
animal and pulverized in a liquid nitrogen-cooled mortar,
then homogenized. Tissue debris and nuclei were pelleted out by centrifugation at 1000 ⫻ g for 10 minutes
three times. Crude membrane preparations were obtained by centrifugation of clarified supernatants at
100,000 ⫻ g for 60 minutes. Subsequently 20-g aliquots
of total protein from membrane-enriched fractions of
MC, 16KC2 cells, or brain were separated by electrophoresis on 10% SDS polyacrylamide slab gels. Membranes
were blocked in 5% dry milk/0.1% Tween/1⫻ PBS solution for 60 minutes and incubated with anti-SUR2 rabbit
antiserum (1:1000 dilution) that reacts with a conserved
region of rat SUR2A/B close to the C-terminus. Following incubation with anti-rabbit HRP-conjugated secondary antibody, SUR2 proteins were demonstrated by a
chemiluminescent assay [26, 34].
RESULTS
RACE cloning of mesangial SUR2
The nested 5⬘-RACE reaction generated amplicons of
0.6 kbp and 2.5 kbp and the nested 3⬘-RACE reaction
yielded amplicons of sizes 3.9 kbp and 4.3 kbp. The 3.9
kbp 3⬘-RACE amplicon was identical to the 4.3 kbp
product but was truncated by 400 bp in the 3⬘ untranslated region (UTR). Alignments of the 2.5 kbp 5⬘-RACE
and 4.3 kbp 3⬘-RACE contigs spanned the 4.6 kbp
rSUR2B cDNA coding region and reconstructed a 6.7
kbp SUR2B sequence. Within the coding sequence,
100% identity with the rSUR2B sequence was established [37]. Further analysis demonstrated a unique 160

bp sequence in the 2.5 kbp 5⬘-RACE product’s 5⬘-UTR.
In addition, the 0.6 kbp 5⬘-RACE and 4.3 kbp 3⬘-RACE
contigs comprise the novel 4.8 kbp mcSUR2B. The presence of the two separate mesangial SUR2B cDNAs was
confirmed by end-to-end PCR with primers specific to
each coding region in reactions with cDNA templates
from a single-stranded 5⬘-RACE rat cDNA library.
The 6.7 kbp SUR2B reading frame is 4635 bp and the
translated protein of 1535 aa is identical to rSUR2B.
The 4.8 kbp mcSUR2B reading frame is 2892 bp and
translates a protein of 964 aa. This peptide has a novel
16 aa insert at the beginning of its amino terminus and
is succeeded by 948 aa that are identical to rSUR2B
in the region spanning exons 13 to 38B. The peptide
alignment of the two mesangial SUR2 is displayed in
Figure 1. Based on sequence identity between mcSUR2B
and rSUR2B, the predicted topology of mcSUR2B as
compared to rSUR2B is displayed in Figure 2 and demonstrates that mcSUR2B lacks the initial 12 rSUR2B
exons [4]. This deletion renders a model whereby the
mcSUR2B N-terminus is intracytoplasmic. The putative
mcSUR2B retains the endoplasmic reticulum retention
signal RKQ that prevents cell surface expression of incompletely assembled KATP. It also has two nucleotide
binding folds, NBF1 and NBF2, that contain the Walker
A and B motifs common to all SUR, and the terminal
exon 38B that imparts diazoxide sensitivity to SUR2Bcontaining KATP [38]. McSUR2B is predicted to have six
transmembrane helices whose peptide sequence is identical to the N-terminal transmembrane domain (TM2) of
rSUR2B. The binding sites for the potassium channel
openers pinacidil and cromakalim were previously localized to this area in SUR2A and SUR2B [39–42]. The
cytoplasmic side of the homologous domain in SUR1
provides a high affinity-binding site for the sulfonylurea
agents, tolbutamide and glibenclamide. Compared to
SUR1 the TM2 in SUR2 has a significantly lesser affinity
for sulfonylureas [43–45].
Mesangial SUR2 gene expression
These studies were performed to determine whether
the smaller SUR2 4.8 kbp cDNA obtained by RACE
cloning represents the dominant 5.5 kbp transcript,
which we previously detected by Northern analysis with
a SUR2 probe (pJGAR7, 28). We generated a 1.9 kbp
Sac I fragment from the 2.5 kbp 5⬘-RACE product,
unique to the rSUR2B cDNA. Predictably, this fragment
hybridized only to the mesangial SUR2 transcript at 7.5
kbp. Using PCR, a 215 bp probe was generated corresponding to the unique 5⬘-sequence of mcSUR2B. This
probe preferentially hybridized to the novel 5.5 kb SUR2
message, confirming that the 4.8 kbp cDNA represented
the 5.5 kb SUR2 mesangial transcript. Finally, the 4.3
kbp Eco RI fragment of pJGAR7 that contains sequence
common to both the 4.8 and 6.7 kbp cDNAs predictably
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Fig. 1. Primary sequence of rat mesangial type 2 sulfonylurea receptors (SUR2). The respective 4635 bp and 2892 bp open reading frames of rat
SUR2B (rSUR2B) and mesangial SUR2B (mcSUR2B) cDNAs were translated, and the putative amino acid sequences are displayed. Vertical
bar (|) denotes sequence identity. The underscore (
) defines the sequence unique to mcSUR2. Italics show the amino acids that correspond
to exon 13 of rSUR2B that begins region of identity between rSUR2B and mcSUR2B. Bold type illustrates the Walker A and B ATP-binding
motifs. Asterisks (*) denote the protein kinase A-dependent phosphorylation sites, open diamonds (䉫) are the protein kinase C-dependent
phosphorylation sites, and the boxed region (䊐) shows the terminal SUR2B-specific, alternatively spliced exon.

hybridized to SUR2 transcripts at 5.5 and 7.5 kb (Fig.
3). Finally, to establish whether the novel mcSUR2B
splice variant was expressed in vivo, RT-PCR was performed on RNA template isolated from microdissected
rat glomeruli. Using a primer pair that amplified the
unique 5⬘-sequence of mcSUR2B, we confirmed the gene
expression of the mcSUR2B splice variant in rat glomeruli. In similar RT-PCR reactions, a large amount of specific product was observed using RNA template from
16KC2 or MC (Fig. 4B).

A major difference among SUR2 splice variants is the
alternative usage of either the terminal 38A exon that
characterizes SUR2A or its 38B counterpart that establishes SUR2B. With gene-specific primers, 38A/B exon
usage was determined in MC. A 446 bp amplicon was
amplified in MC, signifying alternative splicing of only
the 38B exon (Fig. 4A). In parallel studies of heart (positive control) and kidney, 446 and 621 bp amplicons were
amplified in heart, but only a 446 bp amplicon was detected in kidney. Collectively, these data support SUR2A
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Fig. 2. Putative topology of the mesangial
SUR2 protein and rat SUR2B. (Top) The rat
mesangial SUR2B (mcSUR2B) protein is
comprised of a single transmembrane spanning domain (TM) with 6 helices that are
flanked by two cytoplasmic loops. Each loop
contains nucleotide-binding folds (NBF) with
Walker A and B motifs that bind and hydrolyze ATP. The N-terminus is predicted as
intracytoplasmic, distinct from other SUR.
The putative endoplasmic reticulum retention
signal RKQ is shown. Protein kinase A (䉭)and protein kinase C (䊉)-dependent phosphorylation sites and the proposed binding
sites of various sulfonylurea compounds are
indicated. (Bottom) Rat SUR2B topology.

and SUR2B isoform expression in heart, but only SUR2B
in kidney [6].
Because our previous observations implied that sulfonylureas, possibly through SUR2B, regulate MC contractility and extracellular matrix metabolism, investigations
were carried out to determine whether glibenclamide
regulated the mesangial expression of the SUR2B gene.
In two independent studies, glibenclamide (5 M) did
not influence SUR2B expression in serum-deprived MC
after 48 hours of drug exposure (Fig. 5). Longer incubation times were not evaluated. Because the 5.5 kb
SUR2B mesangial transcript became more evident during growth of cells in culture (data not shown) and because Kir6.1 transcripts increased during embryonic development, we sought to determine whether serum
regulated SUR2B expression. Interestingly, the level of
the major 5.5 kbp transcript became undetectable following a 24-hour period of serum deprivation and this
change persisted for at least 48 hours. In contrast, serumdeprivation did not alter expression of the 7.5 kb transcript (Fig. 5).
Mesangial SUR2 protein detection
Using polyclonal anti-SUR2 antibody, multiple bands
were detected from Mr 50 to 170 kD in MC (Fig. 6). By
contrast, in the positive control brain tissue only a 170
kD band was visualized. In membrane-enriched preparations of primary MC and 16KC2 cells, a dominant band
was detected at 108 kD, consistent with the predicted
size of the translated mcSUR2B peptide. Lastly, lesser
signal intensity was evident at ⬃170 kD.

Mesangial Kir6.1 and 6.2 gene expression
To establish mesangial Kir6.1/2 gene expression, RTPCR was performed with gene-specific primers. In MC,
a 402 bp fragment corresponding to Kir6.1 was robustly
amplified, whereas the 318 bp fragment of Kir6.2 was
minimally evident (Fig. 7A). As the Kir6.2 gene is intronless [11], the possibility existed that amplification of
contaminating genomic DNA had contributed to these
results. However, PCR, in the absence of reverse transcription generated no Kir6.2 products negating this possibility. Lastly, in Northern analysis, transcripts of Kir6.1
were strongly detected at 1.7 and 2.7 kb in primary MC,
kidney cortex, whole kidney, and heart. The Kir6.2 transcript of 4.1 kb was only identified in the positive control
heart (Fig. 7B, C).
DISCUSSION
Data from Metzger and colleagues has previously implied the presence of glomerular SUR [46, 47]. This
group demonstrated both low- and high-affinity glibenclamide binding in metabolically active preparations of
rat glomeruli. However, the cell type(s) responsible for
the binding were not unequivocally described and the
presence of contaminating vasculature in their preparations may have accounted for the drug binding. This is
plausible because the existence of glomerular SUR, as
a component of afferent arteriolar KATP, has been established [48]. Moreover, sulfonylurea drug binding to glomerular KATP-bearing renin-producing cells also may
have accounted for their results [49].
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Fig. 3. Mesangial SUR2 gene expression. Differential identification of rat mesangial cell transcripts for SUR2B was carried out with gene-specific
probes in northern analysis as described in the Methods section. (A) Rat kidney SUR2B (rSUR2B) and mesangial SUR2B (mcSUR2B) cDNAs
are shown. Stippled portions correspond to regions of identity. Sac I sites (⫹34 to ⫹1939 bp) define an rSUR2B-specific probe. Eco RI sites
(⫹2440 to ⫹6715 bp) define a probe that detects rSUR2B and mcSUR2B transcripts (pJGAR7). A 215 bp 5⬘-terminal fragment (⫹13 to ⫹227
bp) defines the mcSUR2B-specific probe. (B) The Sac I probe only detects the 7.5 kb SUR2B transcript. The mcSUR2B-specific probe strongly
hybridizes to the 5.5 kb transcript. The pJGAR7 probe hybridizes to transcripts at 5.5 and 7.5 kb.

Our data provide convincing evidence for the existence of at least two mesangial SUR2B, which likely
heterodimerize with Kir6.1 to form mesangial KATP. Two
rat mesangial SUR2B cDNAs were RACE-cloned, and
the cDNAs corresponding to the two most abundantly
expressed mesangial SUR2 transcripts of 5.5 and 7.5 kb
characterized by Asano et al [28]. To date, the longest
SUR2B clone that has been isolated is the 6.6 kb rSUR2B
cDNA obtained from a rat kidney library [37]. The coding region of our 6.7 kb SUR2B cDNA was 4635 bp
and essentially identical to rSUR2B, except for several
nucleotide differences that may represent species-specific variations and that do not affect the primary sequence. In addition, the 5⬘-UTR of the 6.7 kb clone
contains a novel 160 bp sequence, which we presume
resulted from cell-specific alternative splicing.
Despite the 0.7 kbp difference in length compared to
the 5.5 kb mesangial SUR2B transcript, we ascertained
that our 4.8 kbp cDNA contains the same open reading
frame as the larger message. Perhaps the foreshortening

of this clone may be attributable to an inability of our
RACE-based system to negotiate complex topology in
the 5⬘-UTR. Nevertheless, the sequence of mcSUR2B,
the smaller mesangial SUR2B that corresponds to the
5.5 kb transcript, clearly identifies it as a member of
the SUR2 family. From aa 17 to 964, mcSUR2B shares
identity with the region of rSUR2B that spans exons 13
to 38B. However, mcSUR2B is truncated at its N-terminus. This gene has a deletion of the 12 proximal N-terminal rSUR2B exons and a unique 16 aa insert at its
amino terminus, discriminating it from other SUR2
(Figs. 2 and 3). Our topological analysis of mcSUR2B
reveals a single, 6-helix transmembrane spanning domain. By contrast, rSUR2B has three transmembrane
domains (Fig. 3) [4, 37]. Additionally, the mcSUR2B
N-terminus is predicted to be intracytosolic, as opposed
to rSUR2B and other SUR2 wherein the N-terminus resides extracellularly [4]. Lastly, mcSUR2B retains
the transmembrane domain corresponding to TM2 of
rSUR2B. The cytosolic side of this domain binds the

1746

Szamosfalvi et al: Mesangial KATP

Fig. 4. Expression of SUR2 splice variants in rat glomerulus and mesangial cells (MC). RT-PCR reactions were carried out in rat heart,
kidney, primary MC, and microdissected glomeruli, with gene-specific
primers that define expression of mcSUR2B, SUR2A, or SUR2B as
described in the Methods section. Gene products were visualized on
ethidium bromide stained gels. (A) SUR2A and SUR2B are detected
in heart. In kidney and MC, only SUR2B is expressed. No gene product
is seen in the negative control (water). (B) The unique 215 bp 5⬘-terminal fragment of mcSUR2B is detected in 16KC2 and MC and microdissected glomeruli. No gene product is detected in the negative control
(water).

Fig. 6. Detection of mesangial SUR2 proteins. Immunoblotting of
SUR2 proteins was carried out on membrane-enriched fractions of rat
brain, mesangial cells (MC) and 16KC2 cells. The rabbit polyclonal
SUR2 antiserum detects common epitopes of SUR2A and SUR2B near
their C-termini as described in the Methods section. In the positive
control tissue brain, the rat SUR2B is strongly detected at 170 kD. In
MC and 16KC2 cells, the mesangial SUR2B is detected at Mr 108 kD,
while the rat SUR2B is less strongly detected at Mr 170 kD.

Fig. 5. Serum deprivation induces differential gene expression of
SUR2B. Gene regulation of SUR2B by glibenclamide and serum was
examined. Subconfluent mesangial cell cultures were maintained in 20%
serum or serum-deprived and exposed to glibenclamide (5 M) for
times shown. In Northern analysis, a probe that detects both the 7.5
kb rat SUR2B and the 5.5 kb mesangial SUR2B transcript was used
(pJGAR7). Serum-stimulated cells express 5.5 and 7.5 kb transcripts.
After a 24-hour serum deprivation, the 5.5 kb mesangial-specific transcript is undetectable and this down-regulation persists for at least
48 hours. Exposure to glibenclamide did not influence SUR2 gene
expression.

potassium channel opener agents, pinacidil and cromakalim, with high affinity [39–42], and also contains a lowaffinity sulfonylurea binding site [43–45].
In immunoblotting experiments, the apparent molecu-

lar mass of 108 kD of the dominant band agrees with
the size predicted from translation of the 2892 bp open
reading frame of the 4.8 kbp mcSUR2B clone. The less
strongly evident 170 kD band most likely characterizes
expression of the 6.7 kbp rSUR2B cDNA. Previous immunoblotting studies of protein isolates from cell lines
transformed by SUR2A or SUR2B cDNA clearly demonstrated proteins with an apparent mass of 170 kD
[50]. Interestingly, these full-length proteins were not
detected from cardiac sarcolemma [51] or whole mouse
kidney crude membrane preparations [52], although
these tissues express full size SUR2A and SUR2B, respectively [7, 20, 37, 52]. Presumably, immunodetection
of full length SUR2 in MC (and murine cardiac sarcolemma and whole kidney crude membrane preparations)
is difficult. On the other hand, the 108 kD band corresponding to the abundant 5.5 kb mcSUR2B transcript
is convincingly demonstrated and the relative intensities
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Fig. 7. Mesangial Kir6.x gene expression.
RT-PCR reactions with gene-specific primers
of Kir6.1 and Kir6.2 were carried out on 16KC2
cells and mesangial cells (MC). Reaction products were visualized on an ethidium bromidestained gel. (A) Strong Kir6.1 gene expression
is shown for MC and 16KC2 cells, while only
minimal Kir6.2 gene expression is detected.
(B) Kir6.1 cDNA was used as probe in northern analysis. Hybridization to transcripts at
sizes shown is seen in renal cortex, MC, 16KC2
cells, and the positive control, heart. (C) Parallel studies with Kir6.2 cDNA only detected a
transcript in the heart.

of the 170 kD and 108 kD signals on immunoblotting
roughly correspond to their hybridization signal intensities previously determined by Northern blotting [28].
The human SUR2 gene spans more than 100 kbp and
contains no less than 39 exons [11]. Multiple tissue-specific splice variants of SUR2 have been documented in
Northern assays and by RT-PCR, and these variations
may contribute to the functional diversity of KATP [11].
The cDNAs characterized by these studies shared extensive homology with mcSUR2B; however, the 5.5 kb transcript of mcSUR2B was not detected previously in cells
or tissues evaluated, suggesting that MC carry out a
unique alternative splicing event. The two splice variants,
cardiac SUR2A and the vascular smooth muscle cell
(VSMC) SUR2B, differ in their expression of the 38A/B
C-terminal exon. A deletion of exon 38A, with preferential expression of exon 38B in SUR2B, renders VSMC
KATP sensitive to the K⫹ channel opener and vasodilator,
diazoxide [41, 42]. In contrast, cardiac KATP, a tetradimer
of SUR2A and KIR6.2, is diazoxide-insensitive. Our results indicate the exclusive usage of exon 38B by MC
and kidney, consonant with the report of Beesley and
colleagues who characterized the expression of murine
kidney SUR2 [52].
Thus far, regulation of the constitutively expressed
SUR2 gene has not been defined. However, prolonged
exposure of pancreatic ␤ cells to glibenclamide has been
shown to increase SUR1 protein expression and to affects its translocation from the cytosol to membrane [53].
We examined the effects of cyclical mechanical stretch
(data not shown) and glibenclamide on mesangial SUR2
gene expression because sulfonylureas are typically utilized as therapy in diabetic individuals whose glomeruli
are exposed to the pernicious effects of glomerular hy-

pertension and the concomitant distensile forces. However, there was no alteration of MC SUR2 gene expression by either stimulus, even after 48 hours of exposure
to glibenclamide and stretch. However, we did document
that serum deprivation of 24 to 48 hours potently downregulated gene expression of the 5.5 kb mcSUR2B transcript, while transcript levels of the 7.5 kb message remained unchanged. The physiological consequence of
this differential expression is unknown.
In VSMC, SUR2B partners with Kir6.1 to form KATP,
and more rarely, Kir6.2 may represent the ion poreforming subunit. Analogously, for MC to furnish an ion
pore channel to mesangial KATP, they must also express
Kir6.x. In MC, we established robust gene expression of
Kir6.1, and minimal Kir6.2 expression in RT-PCR and
Northern blotting studies. Consequently, our data favor
the assembly of two mesangial KATP, heterodimers of
(rSUR2B:Kir6.1)4 or (mcSUR2B:Kir6.1)4 [22]. Several
investigations have established that the various SUR2
exhibit differential electrophysiological characteristics
[54, 55]. Based on a recent study of Kir6.2 knockout mice,
Kir6.1 represents the functional pore-forming subunit of
VSMC KATP [56]. With analogy to VSMC KATP, one of
the mesangial KATP (rSUR2B:Kir6.1)4 would be predicted
to be activated by the potassium channel openers, pinacidil, nicorandil and diazoxide [39–42] and inhibited by
sulfonylureas [43–45]. In addition, this particular KATP
may be nucleoside diphosphate-regulated rather than
ATP-inhibited [22, 57, 58]. Finally, the second mesangial
would be assembled as (mcSUR2B:Kir6.1)4 and could
manifest an electrophysiologic profile different than
(rSUR2B:Kir6.1)4.
Given the ubiquitous expression of KATP and their
regulation by sulfonylureas, the question arises as to
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whether endogenous ligands for these channels exist [59].
At least for pancreatic ␤ cell KATP (SUR1:Kir6.2)4, there
is one such “endogenous sulfonylurea:” ␣-endosulfine.
This 121 aa polypeptide binds SUR1 with high affinity
and stimulates insulin release through KATP inhibition
[60–62]. We have recently demonstrated that ␣-endosulfine gene (ENSA) is expressed in rat MC and glomeruli
(abstract, J Am Soc Nephrol 11:448A, 2000). We speculate that autocrine endosulfine mediates sulfonylureatype effects via SUR2B. The existence of such an autocrine, and possibly paracrine, system could have broad
implications for diabetic glomerulopathy with its attendant pathophysiologic alterations of mesangial cell contractility and matrix metabolism.
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APPENDIX
Abbreviations used in this article are: ABC, ATP-binding cassette;
ANP, atrial natriuretic peptide; ATP, adenosine 5⬘-triphosphate;
CFTR, cystic fibrosis transmembrane regulator; DMSO, dimethyl sulfoxide; ECL, enhanced chemiluminescence; FCS, fetal calf serum; KATP,
ATP-sensitive K⫹ channel; Kir6.1, inwardly-rectifying K⫹ channel 6.1;
MC, mesangial cell; MESA, morpholinopropane sulfonic acid-EDTAsodium acetate; MRP, multidrug resistance protein; RACE, rapid amplification of cDNA ends; RT-PCR, reverse transcription-polymerase
chain reaction; SUR, sulfonylurea receptor; SUR2B, type 2B sulfonylurea receptor; UTR, untranslated region; VSMC, vascular smooth
muscle cells.
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